The Impact of the COVID-19 Pandemic on the Incidence, Severity, and Management of Acute Appendicitis: A Single Center Experience in Thailand
Table 1
Demographic data of adult patients with acute appendicitis.
Pre-COVID-19 (n = 574)
During COVID-19 (n = 434)
value
Age, mean ± SD (years)
37.46 ± 17.1
37.99 ± 17.6
0.680
Median (iqr)
33 (23, 49)
33 (23, 52)
Gender male/female
299/275
216/218
0.465
BMI, (Kg/m2)
23.08 ± 4.23
23.45 ± 4.48
0.179
Underlying disease, (%)
Hypertension
73 (12.72)
60 (13.82)
0.607
Diabetes mellitus
34 (5.92)
30 (6.91)
0.524
Heart disease
7 (1.22)
11 (2.53)
0.119
Airway disease
10 (1.74)
18 (4.15)
0.021
Vascular disease
10 (1.74)
10 (2.30)
0.526
Chronic kidney disease
7 (1.22)
15 (3.46)
0.016
Immunocompromise
12 (2.09)
9 (2.07)
0.985
ASA classification
1
462 (80.49)
269 (61.98)
<0.001
2
102 (17.77)
128 (29.49)
<0.001
3
9 (1.57)
34 (7.83)
<0.001
4
0 (0)
3 (0.69)
0.046
5
0 (0)
0 (0)
Sign and symptom, (%)
Self-report symptom, (hours)
Mean ± SD (years)
35.10 ± 49.47
36.36 ± 48.73
0.686
Median (iqr)
24 (12, 48)
24 (10, 48)
Nausea/vomiting
355 (61.95)
283 (65.21)
0.289
RLQ pain
523 (91.27)
337 (77.65)
<0.001
Migratory pain
337 (58.81)
193 (44.47)
<0.001
Fever
268 (46.77)
130 (29.95)
<0.001
Diarrhea
134 (23.39)
107 (24.65)
0.640
Anorexia
250 (43.63)
198 (45.62)
0.529
Rebound tenderness
283 (49.48)
204 (47.00)
0.437
Body temperature, (°C)
37.29 ± 0.74
36.94 ± 0.68
<0.001
Systolic blood pressure, (mmHg)
123.06 ± 16.81
124.40 ± 17.75
0.224
Diastolic blood pressure, (mmHg)
73.18 ± 10.91
74.05 ± 12.22
0.235
Pulse rate, (beats/minute)
89.59 ± 15.76
92.77 ± 18.75
0.004
Respiratory rate, (beats/minute)
19.72 ± 1.45
20.10 ± 2.01
<0.001
Laboratory test, (%)
Leukocytosis
405 (70.56)
311 (71.66)
0.703
Neutrophils predominate
432 (75.26)
361 (83.18)
0.002
ASA, American Association of Anesthesiologist; BMI, body mass index; iqr, interquartile range; RLQ, right lower quadrant; SD, standard deviation, Statistically significant value <0.05, nonparametric data.
